This is the authors' abstract. We don't add key points for this paper.
Abstract ( R )‐(−)‐2‐[ 11 C]Methoxy‐ N ‐ n ‐propylnorapomorphine ([ 11 C]MNPA ([ 11 C]2)) is an agonist radioligand of interest for imaging D 2 /D 3 receptors in vivo . Here we sought to develop an improved radiosynthesis of this radioligand. Reference 2 was synthesized in nine steps with an overall yield of about 5%, starting from codeine. Trimethylsilyldiazomethane proved to be a practical improvement in comparison to diazomethane in the penultimate methylation step. A protected precursor for radiolabeling (( R )‐(−)‐2‐hydroxy‐10,11‐acetonide‐ N ‐ n ‐propylnoraporphine, 4) was prepared from ( R )‐(−)‐2‐hydroxy‐ N ‐ n ‐propylnorapomorphine (1) in 30% yield. [ 11 C]2 was prepared from 4 via a two‐step one‐pot radiosynthesis. The first step, methylation of 4 with [ 11 C]methyl triflate, occurred in quantitative radiochemical yield. The second step, deprotection of the catechol moiety with HCl and heat, yielded 60–90% of [ 11 C]2 giving an overall incorporation yield from [ 11 C]methyl triflate of 60–90%. In a typical run more than 1 GBq of [ 11 C]2, was produced from carbon‐11 generated from a 10‐min proton irradiation (16 MeV; 35 µA) of nitrogen–hydrogen target gas. The radiochemical purity of [ 11 C]2 was > 99% and specific radioactivity at the time of injection was 901±342 GBq/µmol ( n =10). The total synthesis time was 35–38 min from the end of radionuclide production. The identity of [ 11 C]2 was confirmed by comparing its LC‐MS/MS spectrum with those of reference 2 and ( R )‐(−)‐10‐methoxy‐2,11‐dihydroxy‐ N ‐ n ‐propylnoraporphine.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Steiger et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: